Immune Checkpoint Inhibitors Did Not Exacerbate Autoimmune Rheumatic Disease Activity in Patients With Cancer
The findings suggest that ICI treatment does not significantly increase the risk of ARD flare-ups in patients with cancer and preexisting or acquired ARDs.
Authors
- Yu-Ching Wang
- Ping-Han Tsai
- C. Kuo
- Yung-Chia Kuo
- Shao-Ming Yu
- Chen-I Hsieh
Institutions
- University of Nottingham (GB)
- Chang Gung University (TW)
- National Tsing Hua University (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
- Taipei City Hospital (TW)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2026-02-01
- DOI
- https://doi.org/10.6004/jnccn.2025.7106
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00